Reduced EDSS progression in multiple sclerosis patients treated with modafinil for three years or more compared to matched untreated subjects

Background: Modafinil is a wakefulness-promoting drug used to treat narcolepsy, obstructive sleep apnoea, and shift-work sleep disorder. Modafinil has also been used for the treatment of fatigue and excessive sleepiness in other neurological disorders including multiple sclerosis, psychiatric disord...

Full description

Bibliographic Details
Main Authors: Bibani, R, Tench, C, George, J, Manouchehrinia, A, Palace, J, Constantinescu, C
Format: Journal article
Language:English
Published: 2012